Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

US Patent 9790210 · Granted Oct 17, 2017

Estimated economic value: $7,871,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2025
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fl2025
FGFR3 inhibitor compounds2025
Protein tyrosine phosphatase inhibitors2025
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fl2024
Antiproliferative compounds and methods of use thereof2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
RET kinase inhibitors2024